Prof. Dr.
A. Kemal BAYÜLKEM

Contact

E-appointment

Prof. Dr.
A. Kemal BAYÜLKEM

Neurology

He was born in 1941 in Istanbul. He completed his primary and secondary education at Fatih Primary School, Gelenbevi Secondary School and Vefa High School. He completed his medical education at Istanbul University Faculty of Medicine and his specialty training at Istanbul University Cerrahpaşa Faculty of Medicine, Department of Neuropsychiatry. He worked as a faculty member in Samsun Military Hospital, S.B. Samsun State Hospital, Şişli Etfal Training and Research Hospital, Haseki Training and Research Hospital, Adnan Menderes University Faculty of Medicine Department of Neurology, Consultant Neurologist in American and German Hospital, Neuropsychiatry specialist in Turkish Heart Foundation Neurocardiology Center. Scientific studies abroad: As Visiting Neurologist, Department of Neurology in ST Thomas Hospital and National For Nervous Disease London / UK. Following her work as a Postdosctoral Research Fellow in sleep disorders, Parkinson’s diseases and movement disorders clinic, Restorative neurology and Human neurobiology in Baylor College of Medicine Houston / Texas, Parkinson’s clinic NIH, NINDS, BETHESDA, MD- USA as Adjunct investigator, she continues to serve at Private Medikent Hospital since 2018.

He is married and has two children. His hobbies include classical music, traveling, theater, watching football and volleyball matches and hiking.

Prof. Dr. A. Kemal BAYÜLKEM
Neurology

Detailed information

Education

High School VEFA HIGH SCHOOL

University ISTANBUL UNIVERSITY FACULTY OF MEDICINE, 1967: IST. UNIVERSITY. CERRAHPASA FACULTY OF MEDICINE (NEURO-PSYCHIATRY SPECIALIST) 1971

Associate Professorship NEUROLOGY . EGE UNIV. FACULTY OF MEDICINE, NEUROLOGY ABD, 1981

Professorship NEUROLOGY AYDIN ADNAN MENDERES UNIV. FACULTY OF MEDICINE, DEPARTMENT OF NEUROLOGY, 1995

Working Organizations

DOMESTIC :

1967/ 1971 : CERRAHPASA MEDICAL FACULTY, NEUROPSYCHIATRY ABDOMEN

1971/ 1973 : SAMSUN MILITARY HOSPITAL (RESERVE OFFICER)

1973/ 1977 : S.B. SAMSUN STATE HOSPITAL

1977/ 1984 : S.B. ŞİŞLİ ETFAL EDUCATION AND RESEARCH HOSPITAL NEUROLOGY

CHIEF OF THE CLINIC. MV. – ISTANBUL

1984/ 1994 : S.B. HASEKI EDUCATION AND RESEARCH HOSPITAL NEUROLOGY CLINIC. CHIEF

1994/ 1997 : ADNAN MENDERES UNIV. MEDICINE FACULTY FACULTY MEMBER OF NEUROLOGY DEPARTMENT

1987/ 2005 : KOCAELI UNIVERSITY MEDICINE FACULTY FACULTY MEMBER OF NEUROLOGY DEPARTMENT

2005/ 2008 : IST. UNIVERSITY. CERRAHPASA FACULTY OF MEDICINE FACULTY MEMBER OF NEUROLOGY DEPARTMENT

OTHER INSTITUTIONS HE WORKED FOR :

DOMESTIC :

6/ 1988- 12/1994 AMERICAN HOSPITAL

9/1999-8/ 2003: GERMAN HOSPITAL ISTANBUL

1/2001-1/2007 : TURKISH HEART FOUNDATION / ISTANBUL

FOREIGN :

1/ 1986 -3/1986 : CONSULTANT NEUROLOGIST, DEPARTMENT OF NEUROLOGY . ST: THOMAS HOSPICE AND NATIONAL HOSPICE /LONDON / UK

5/1987- 11/1987 : POSTDOCTORAL RESEARCH FELLOW.

IN SLEEP DISORDERS AND RESEARCH CENTER DEPARTMENT OF PSYCHIATRY BAYLOR COLLEGE OF MEDICINE / HOUSTON-TX-USA

4/12/ 1987- 3/11/1988 : CONSULTING NEUROLOGIST PARKINSON’S DISEASE CENTER AND MOVEMENT DISORDERS CLINIC .IN DEPARTMENT OF NEUROLOGY BAYLOR COLLEGE OF MEDICINE / HOUSTON / TX – USA

3/1/1988/ 5/1/1988 : CONSULTING NEUROLOGIST, DEPARTMENT OF RESTORATIVE NEUROLOGY AND HUMAN NEUROBIOLOGY, BAYLOR COLLEGE OF MEDICINE, HOUSTON / TX – USA

1/2007/ 1/ 2008 : ADJUNCT INVESTIGATOR IN MEDICAL NEUROLOGICAL BRANCH

IN PARKINSON CLIIC, NIH, NINDS, BETHESDA, MD-USA

2009/2017 : SPECIAL VOLUNTEER AND ADJUNCT INVESTIGATOR.

Professional Activities

9/1190-10/1992: S.B HASEKI EDUCATION AND RESEARCH HOSPITAL CHAIRMANSHIP OF THE SCIENTIFIC COMMITTEE

1/1990-12/1994: GENERAL SECRETARIAT OF TURKEY HOSPITAL CONTRACTING ASSOCIATION

10/1995 : ORGANIZATION OF THE FIRST PARKINSON’S DISEASE MOVEMENT DISORDERS SYMPOSIUM . ADNAN MENDERES UNIV, FACULTY OF MEDICINE. DEPARTMENT OF NEUROLOGY – AYDIN


2/2002 : NEUROCARDIOLOGY CENTER AT TURKISH HEART FOUNDATION

ESTABLISHMENT AND CHAIRMANSHIP

4/2003: 1. ORGANIZATION OF NEUROCARDIOLOGY SYMPOSIUM / TURKISH HEART FOUNDATION / ISTANBUL

11/2004: 1. ORGANIZATION OF THE INTERNATIONAL PARKINSON’S DISEASE AND PARKINSONISM SYMPOSIUM / ISTANBUL

6/2006 : 2. INTERNATIONAL PARKINSON’S DISEASE ORGANIZATION OF PARKINSONISM AND PARKINSONISM SYMPOSIUM / ISTANBUL

Main Areas of Interest

HEADACHE / TENSION HEADACHE

CEREBROVASCULAR DISEASES – STROKES (HEMORRHAGE-ISCHEMIC OBSTRUCTION)

MIGRAIN

DIZZINESS (VERTİGO)

PARKINSON’S DISEASE AND OTHER MOVEMENT DISORDERS

RESTLESS LEG SYNDROME

TREMOR

EPILEPSY

DEMANS : ALZHEIMER’S DISEASE, VASCULAR DEMENTIA AND OTHERS

EMOTIONAL STRESS AND PSYCHOSOMATIC DISEASES

PSYCHONEVROSES

DIABETIC NEURAPATHY

TRIGEMINAL NEURALGIA

PERIPHERAL FACIAL PARALYSIS

MUSCLE DISEASES : MYASTHENIA GRAVIUS, MYOPATHY – POLYMYOSITIS, DERMATOMYOSITIS AND OTHERS.

PSYCHIATRIC ILLNESSES : DEPRESSION, SCHIZOPHRENIA AND PARANOID SYNDROME, ANXIETY ATTACKS AND PANIC DISORDER, SOCIAL PHOBIA, BIPOLAR DISORDER

MEMBER ORGANIZATIONS

  • NEUROLOGY ASSOCIATION OF TURKEY
  • TURKISH NEURO-PSYCHIATRY ASSOCIATION
  • TURKISH ASSOCIATION FOR THE FIGHT AGAINST EPILEPSY
  • TURKISH ASSOCIATION OF CEREBROVASCULAR DISEASES
  • TURKISH HEART FOUNDATION
  • UNION OF TURKISH PHYSICIANS
  • ALZHEIMER’S ASSOCIATION
  • HEALTH AND SOCIAL WELFARE FOUNDATION
  • MOVEMENT DISORDERS SOCIOCTY
  • AMERICAN ACADEMY OF NEUROLOGY
  • KIRKLARELI CHAMBER OF PHYSICIANS
  • ISTANBUL CHAMBER OF PHYSICIANS
Administrative Duties

– GENERAL SECRETARIAT OF THE ASSOCIATION OF HOSPITAL UROLOGISTS OF TURKEY

  • SB HASEKI HOSPITAL CHAIRMANSHIP OF SCIENTIFIC COMMITTEE
  • FOUNDING CHAIRMAN OF ADNAN MENDERES UNIVERSITY FACULTY OF MEDICINE NEUROLOGY ABDOMEN
  • ADNAN MENDERES UNIV. DEPARTMENT OF INTERNAL SCIENCES OF FACULTIES OF MEDICINE
  • CHAIRMANSHIP OF THE NEUROCARDIOLOGY SOCIETY AT THE TURKISH HEART FOUNDATION

SELECTED PUBLISHED CLINICAL RESEARCH STUDIES

Bayulkem K and Ozdamar E. Frequency and side effects of L-dopa in Parkinsonism. The Journal of Cerrahpasa Medical Faculty 1974; 3:161-164.

Bayulkem K and Ozdamar E. Biochemical investigation of L-dopa effect in Parkinsonism. The Journal of Cerrahpasa Medical Faculty 1974; 5:4-6.

Aktuna Y, Bayulkem K, Forta H, Kirbas D. Bromocriptine in Parkinsonism. The Medical Bulletin of Sisli Etfal Hospital 1979; 1:23-24.

Bayulkem K. Sural nerve velocity in diabetes mellitus. The Medical Bulletin of Sisli Etfal Hospital 1979; 4: 239-246.

Bayulkem K. Motor nerve conduction velocity in diabetes mellitus. The Medical Bulletin of Sisli Etfal Hospital 1981; 1-4: 42-84.

Bayulkem K. Sorbitol metabolism in diabetic polyneuropathy. Annual book of Diabetes 1983; 1: 280-310.

Bayulkem K. Demonstration of the result obtained by bromocriptine therapy in a patient presenting with serious symptoms of Parkinsonism (Video- tape).(It was presented in XVIII. Balkan Medical Congress, 1984, Istanbul.

Pala O and Bayulkem K. Treatment of Wilson’s disease with oral zinc sulphate. The Medical Bulletin of Haseki Hospital 1988; 4:385-388. 5

Erisir K and Bayulkem K. Evaluation with Webster Scale of clinical symptoms in patients with Idiopathic Parkinson’s disease on L-dopa + benserazide treatment. The Medical Bulletin of Haseki Hospital 1990; 2:105-111.

Karanfil H, Bayulkem K, Erisr K. Investigation of palmomental reflex in Parkinson’s disease and Pseudobulbar paralysis. The Medical Journal of Turkish Hospitals 1992; 2: 63-69.

Tonyali B, Bayulkem K,Tuncberk S. Serum lipid and lipoprotein changes in cerebrovascular disease. The Medical Bulletin of Haseki Hospital 1993; 3:175-179.

Bayulkem K, Ulusoy K, Demiralp T. Visual evoked potentials in the idiopathic Parkinson’s disease. Istanbul Beyoglu Scientific Publication 1994; 1-4:12-16.

Temir S, Bayulkem K, Tek, K. Visual evoked potentials in cerebral infarcts. The Medical Bulletin of Haseki Hospital 1995; 33:21-29.

Bayulkem K, Kaya G, Tuncel A, Disci R. L-dopa + benserazide HBS in the treatment of Parkinson’s disease. The Medical Bulletin of Haseki Hospital 1996; 1:35-39.

Bayulkem K, Erisir K, Tuncel A, Bayulkem B. A study on the effect and tolerance of lisuride on Parkinson’s disease. Advances in Neurology, Volume 69, edited by L. Battistin, G. Scarlato, T. Caraceni and S. Ruggieri. Lippincott-Raven Publishers, Philadelphia, 1996; 65:519-530.

Turgut M and Bayulkem K. Cerebrovascular occulusive disease: Hydatidosis. Child’s Nerve Syst., Springer-Verlag, 1998; 14: 697-699.

Efendi H, Gonenc Z, Budak F, Bayulkem K, Komsuglu S. Visual and auditory evoked potentials in Parkinson’s disease. Journal of Turkish Parkinson’s disease Society 1999; 2(1):10-13.

Efendi H, Budak F, Gonenc Z, Bayulkem K, Komsuoglu S. Cerebral MRI, SPECT and clinical Correlation in Parkinson’s disease. Journal of Turkish Parkinson’s Disease Society 1999; 2(2):13-17.

Akyol A, Mungen, B, Turgut M, Akarsu S, Bolukbasi O, Bayulkem K. Treatment of juvenile Migraine with subcutaneous sumatriptan. Curr. Paed. Res 1999; 3(1):33-36.

Bayulkem K, Akyol A, Bayulkem G, Bayulkem B, Genel H. The efficacy of pergolide added to L-dopa in the treatment of Parkinson’s disease. The Medical Bulletin of Haseki Hospital 2001; 39: 194-200.

Bayulkem K. and Torun F. Venlafaxine versus sertraline in patients with depression in Parkinson’s disease. The book of 7th Congress of European Soceity for Clinical Neuropharmacology, (Ed. L. Battistin) Trieste (Italy), May 5-9, 2004, Medimond, International proceedings 2004; 219-226.

Bayulkem K, Efendi H, Karabas G. Therapeutic efficacy and tolerability of olanzapine in essential tremor. The book of 7th Congress of European Society of Clinical Neuropharmacology, (Ed. L. Battistin) Trieste (Italy), May 5-9, 2004, Medimond, International proceedings 2004; 2004; 91-96.

Sazci A, Ergul E, Bayulkem K. Association of the C677T and A1298C polymorphisms in the Methylenetetrahydrofolate reducase gene in patients with essential tremor in Turkey. Movement Disorders 2004; 19, 12:1472-1476.

Torun F, Bayulkem K, Torun SD. Efficacy of Sertraline in the Treatment of Depression in Patients with Parkinson,s disease. Turkiye Klinikleri J Med Sci 2010; 30(6):18527. 6

Torun F, Bayulkem K, Torun SD. Efficacy of Venlafaxine in the Treatment of Depression in Patients with Parkinson’s disease. Bulletin of Clinical Psychopharmacology 2011; 21(1) : 18-23.

Andican G, Konukoglu D, Bozlucay M, Bayulkem K, Firtina S, Burcak G. Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson`s disease. Acta Neurologica Belgica 2012; 112(2):155-159.

PARTICIPATION IN CLINICAL RESEARCH

Co-Investigator in” Neuropathological features in different focal dystonias”.National Institute of Neurological Disorders and Stroke ,NIH, Bethesda, MD: A retrospective study ,10/2014-present

Principal investigator Clinical Trial Sponsor: Investigation Fund of Rector ship of Istanbul University, Istanbul, Turkey

Protocol No: 556/14082006, Can serum and urine 8-Hydroxydegunisine levels be a biomarker of oxidative stress and following up of the prognosis in Parkinson’s disease? 04/2006-12/2008

Neurology and Biochemistry Departments of Cerrahpasa Medical Faculty, Istanbul UniversityTurkey.

Co- Investigator NIH 4/2007-present. National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.

Protocol 07-N-0137, expanding the phenotype of the LRRK2 mutation in Individuals with history of Parkinson’s disease and their relatives: a prospective study

OTHER CLINICAL RESEARCH STUDIES (Poster Presentations):

Erisir K, Bayulkem K, Yilmaz E. Determination of vanillyl mandelic acid and 5-Hydroxy indole acetic acid amounts in the urine before and after L-dopa+benserazide therapy in Parkinson’s disease and investigation of correlation with its clinical symptoms. Journal of Endocrinological Investigation European Neuroendocrin Association, E.N.E.A. Abstract of Commnications 1991; Vol.14/Suppl.4-6:91.

Bayulkem K. The research of the relation between depression and seratonergic system in Parkinson’s Disease. Journal of Endocrinological Investigation, E .N.E.A. Abstract of Communication 1991; Vol.14/Suppl.4-6:91.

Bayulkem K. The incidence and characteristics of pain in idiopathic Parkinson’s disease. Abstract Book of the Second International Congress of the Movement Disorders 1992; 224.

Bayulkem K. Erisir K, Tuncel A. A study on the response of writing tremor to treatment by primidone. Abstract Book of the Second International Congress of the Movement Disorders 1992; 190.

Bayulkem K and Kaya G. The therapeutical effect of oral zinc sulphate treatment in the Wilson’s disease. Abstract Book of the Third International Congress of Movement Disorders 1994 Vol.9/Suppl.1:56.

Bayulkem K, Barlas O, Turgut M, Soyer P, Kiziltan M, Kaya G, Mert M. Improvement by neurosurgical treatment in medically intractable persistent unilateral Parkinsonism. Abstract Book of the Fourth International Congress of Movement Disorders 1996 Vol.11/ Suppl. 1:242. 7

Bayulkem K, Tuncberk S, Turgut M, Tanor O. Results of Clinical examination computed tomography findings and neuropsychological tests in patients with thalamic hemorrhage. Abstracts, 10th International Symposium on Cerebral Hemodynamics.Cerebrovascular Disease, CDISE7/6 1996; Suppl.3,1-74:31.

Bayulkem K, Turgut M, Akyol A, Genel H. Headache in Parkinson’s disease: An evaluation of risk Factors .Journal of Neurological Sciences for Basic and Clinical Research. Abstracts of the XVIth World Congress of Neurology, Elsevier 1997; Vol.150/Suppl: 3.

Turgut M, Bayulkem K, Temocin A K, Genel H. Family history in patients with low back pain. Journal of Neurological Sciences for Basic and Clinical Research. Abstracts of the XVIth World Congress of Neurology, Elsevier 1997; Vol.150/Suppl: 335.

Bayulkem K, Efendi H, Gonenc Z, Ozkarakas H. Stapedial reflex in idiopathic Parkinson’s disease. Parkinsonism and Related Disorders.Abstracts of the XIIIth International Congress on Parkinson’s Disease, Elsevier Science Ltd. 1999; Vol.5/Suppl: 36.

Bayulkem K and Torun F. Effectiveness of sertraline in treatment of depression with Parkinson’s disease. Abstracts of Movement Disorders Society’s Seventh International Congress of Parkinson’s Disease and Movement Disorders 2002;Vol.17/Suppl.5:203.

Bayulkem K, Efendi H, Karabas G. Clinical efficacy of Mirtazapine in patients with essential tremor. Abstracts of Movement Disorders Society’s Seventh international Congress of Parkinson’s Disease and Movement Disorders 2002; Vol.17/Suppl.5:1145.

Bayulkem K, Efendi H, Karabas G. Demographic and clinical characteristics of essential tremor in Kocaeli City. Abstracts of the Movement Disorders Society’s Seventh International Congress of Parkinson’s disease and Movement Disorders 2002; Vol.17/ Suppl.5:1148.

Bayulkem K, Gurpinar B, Bayulkem G, Aslantugrul E, Yildiz Y, Bayulkem B. Plasma homocysteine, folate and vitamin B12 levels in patients treated with Parkinson’s disease. Abstracts of Movement Disorders Society’s Eight Internatioal Congress of Parkinson’s disease and Movement Disorders 2004; Vol.19/ Suppl.9:721.

Iseri P, Bayulkem K, Efendi H, Okay T, Karabas G. L-dopa dependence in a young adult patient with Parkinson’s disease. Abstracts of Movement Disorders Society’s Eight International Congress of Parkinson’s disease and Movement Disorders 2004; Vol.19/Suppl.9:792.

Sazci A, Akpinar G, Ergul E, Idrisoglu HA, Kara I, Bayulkem K. Association of catechol-omethyl transferase gene Val158 Met polymorphism with Parkinson’s disease. Abstracts of Movements Disorders Society’sEleventh International Congress of Parkinson’s Disease and Movement Disorders 2007; Vol.22/ Supp.16:S76.

Akpinar G, Ergul E, Sazci A, Kara I, Idrisoglu HA, Bayulkem K. Angiotensin I-converting enzyme gene I/D polymorphism and Parkinson’s disease. Abstracts of Movement Disorders Society’s. Abstracts of Movement Disorders Society’s Eleventh International Congress of Parkinson’s Disease and Movement Disorders 2007; Vol.22/suppl. 16:S83.

Akpinar G, Ergul E, Kara I, Idrisoglu HA, Bayulkem K, Sazci A. Apoliporotein E polymorphism and Parkinson’s disease. Abstracts of Movement Disorders Society’s Eleventh International Congress of Parkinson’s Disease and Movement Disorders 2007; Vol.22/suppl. 16:248. 8

Ergul E, Sazci A, Bayulkem K. Lack of association between catecholamine-o-methyl transferase Val158. Met polymorphism and essential tremor. Abstracts of Movement Disorders Society’s Eleventh International Congress of Parkinson’s Disease and Movement Disorders 2007; Vol.22 Suppl.16:S289.

Lopez G, Bayulkem KChoi JH, McElroy B, Crews C, Brooks M, Gupta N, Velayati A, Angela Britton A, Sidransky E, and Hallett M. Cognitive impairment in Parkinson`s patients with GBA mutations.7 th International Congress on Mental Dysfunctions & Other Non-motor features in Parkinson`s disease and Related Disorders (MDPD 2010) Barcelona, Spain,9-12 December (in Abstract Book).

Lopez G, Bayulkem K, Mc Elroy B, Crews C, Brooks M, Bayulkem B, Hallett M. Olfactory dysfunction correlation to non-motor symptoms in Parkinson`s disease patients. 16 th International Congress of Parkinson`s Disease and Movement Disorders. Dublin, Ireland on June 17- 21,2012(inCongress`s cd).

SELECTED PUBLISHED REVISION STUDIES:

Bayulkem K. Orthostatic hypotensions. Medical Bulletin of Sisli Etfal Hospital 1978; 4:310- 320.

Bayulkem K. Perception disorders. Medical Bulletin of Sisli Etfal Hospital 1978; 1978; 3:288-296.

Bayulkem K. Intracranial hypertension syndrome and pseudotumor cerebry. Medical Bulletin of Sisli Etfal Hospital 1979; 3:179-196.

Bayulkem K. Diabetic Polyneuropathy. Symptomatology, classification and frequency. Medical Bulletin of Sisli Etfal Hospital 1979; 3:197-207.

Bayulkem K. Dopaminergic Agonists. Medical Bulletin of Sisli Etfal Hospital 1980; 1- 4:111-116.

Bayulkem K. Hypersomnia Syndromes. Medical Bulletin of Sisli Etfal Hospital 1980; 1- 4:25-28.

Bayulkem K. Parietal Lobe: Anatomy, Physiology and Symptomatology. Medical Bulletin of Sisli Etfal Hospital 1980; 1-4:90-101.

Bayulkem K. Ethiopathogenesis in diabetic polyneuropathy. Medical Bulletin of Sisli Etfal Hospital 1981; 1-4:128-141.

Bayulkem K. Jealousy, Maya 1985; 44:80-81. Bayulkem K. Neurogenic Shock. Medical Bulletin of Haseki Hospital (Special Journal for Shock Panel) 1985; 45-62.

Bayulkem K. Mental problems in young persons: Causes and proposals. Medical Bulletin of Haseki Hospital 1985; 4:363-370.

Bayulkem K. The tissue transplantation to the brain and the treatment of Parkinson’s disease. Medical Bulletin of Haseki Hospital 1987; 25(1) 67-74.

Bayulkem K. Migraine treatment. Medical Bulletin of Haseki Hospital 1988; 4:330-342. 9

Bayulkem K. The role of nocturnal penile investigations in sleep lab in impotence diagnosis and treatment. Medical Bulletin of Haseki Hospital 1988; 1:1-14.

Bayulkem K. Parasomnia. Medical Bulletin of Haseki Hospital 1988; 2:1-20.

Bayulkem K. Sleep in persons with disease involving nervous system’s organic disorders. Medical Bulletin of Haseki Hospital 1988; 4:290-313.

Bayulkem K. Clinical features and differential diagnosis of blepharospasm and idiopathic cranio-cervical dystonia (Meige syndrome). Medical Bulletin of Haseki Hospital 1988; 2:165-176.

Bayulkem K. Sleep disorders and clinical, genetic findings. Medical Bulletin of Haseki Hospital 1989; 1:20-23.

Bayulkem K. Clinical, genetic findings and sleep disorders in Tourette syndrome. Medical Bulletin of Haseki Hospital.1989; 1:20-23.

Soyer P and Bayulkem K. Poliomyelitis regarding neurological aspects. Medical Journal of Turkish Hospitals 1995; 2:21-23.

Bayulkem K. The approach to clinical diagnosis in Parkinson’s disease and clinical symptomatology in Parkinson-plus syndromes. In Parkinson’s disease and Movement Disorders. Edited by Kemal Bayulkem. Aydin, 1996; 43-47.

Turgut M, Akyol A, Bayulkem K. Limbic system. Anatomy, physiology, clinic and surgery. Medical Bulletin of Haseki Hospital 1997; 1:75-80.

Bayulkem K. Multiple System Atrophies. Journal of Turkish Parkinson’s Disease Soceity1999;2(1):39-41.

Bayulkem K. Dopamine receptor agonists in treatment of Parkinson’s disease.Dirim1999;9- 10:273-289.

Bayulkem K. Nitric oxide.Its relation with Parkinson’s disease and apoptosis.Dirim1999;11-12:327-333.

Bayulkem K. The psychology of earthquake and stress. Serve Organization. Health 2000; 47-48.

Bayulkem K. Interaction of heart and brain in our life. Journal of Turkish Heart Foundation 2000; 7-8.

Bayulkem K. Stroke and risk factors. Journal of Turkish Heart Foundation 2002; 30-31

Bayulkem K. Cardiovascular symptoms and findings in diabetic neuropathy. The Booklet of I International Neurocardiology Symposium 2003; 21-22.

Bayulkem K. Menopause psychology. Journal of Turkish Heart Foundation 2003; 6-7.

Bayulkem K. What is Neurocardiology? Journal of Hippocrates 2003; 3:80-81.

Bayulkem G and Bayulkem K. Hyperhomocysteinemia in Parkinson’s disease: L-dopa 10 treatment, folate deficiency and effects of MTHFRC677T genotype. Journal of Hippocrates 2004; 2:93- 95.

Bayulkem K. Clinical Neurocardiology. Medical Network, Actual Medicine 2006; 5:58-61.

Bayulkem K. Corticobasal degeneration. Abstract book of II. International Parkinson’s disease and Parkinsonism Symposium 2006; 16.

Bayulkem K and Torun F.Treatment of depression in Parkinson’s disease.Yeni Symposium 2007; 1:14-20.

Bayulkem K. The effect of emotional stress on cardiovascular system. Abstract book of II.Internatioal Neurocardiology Symposium 2009; 33-34.

Bayulkem K and Lopez G. Nonmotor fluctuations in Parkinson’s disease: Clinical spectrum and classification. Journal of the Neurological Sciences 2010; 289:89-92

Bayulkem K and Lopez G. Clinical approach to nonmotor sensory fluctuations in Parkinson`s disease. Journal of the Neurological Sciences 2011; 310 (1-2):82-85

Lopez G, Bayulkem K, Hallett M. Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants. Acta Neurol Scand DOI: 10.1111/ane.12546 (Published 2016.This article is a US. Goverment work and is in the public domain in the USA).

SOME CASE PRESENTATIONS (Poster Presentations)

Soyer P, Bayulkem K, Karanfil H, Erisir K, Deva E. A neural-leprosy case involving N.Ulnaris bilaterally as clinical and electrophysiological. XXV. National Psychiatry and Neurological Sciences Congress. The book of Presentation Summaries 1989:77-78.

Bayulkem K. Etiological causes in hemifacial spasm: A case report (Clinical evaluation and importance of Botilinum toxin in its treatment). II.National Neurology Congress, the book of Presentation Summaries 1989; 93.

Bayulkem K. Erisir K, Karanfil H. A Neuropolymyositis Case with involved distally resembling to Charcot Marie Tooth’s disease.II.National Neurology Congress, the Book of Presentation Summaries, 1989:97.

Bayulkem K, Akcetin M, Tanyeri S, Bahar S, Coban O. A Subarachnoid hemorrhage case due to spinal arteriovenous malformation.III. National Neurology Congress, the Book of Presentation Summaries 1990:79.

Tanyeri S, Feyzaoglu H, Bayulkem K, Kuyubasi Z. A Sialore case.III.National Neurology Congress,The Book of Presentation Summaries 1990:103.

Bayulkem K, Korkmaz E, Akcetin M. Postanoxic myoclonus (Lance-Adams syndrome): A case report. III.National Neurology Congress, the Book of Presentation Summaries 1990:109.

Ornek I, Bayulkem K, Mumoglu S. A Benign intracranial hypertension case due to bilaterally polycystic ovary. III.National Neurology Congress, the Book of Presentation Summaries 1990:117-118. 11

Kendirli Y, Soyer P, Mumoglu S, Bayulkem K. Steinert`s disease: A case report. III.National Neurology Congress, the Book of Presentation Summaries 1990:113.

Korkmaz E, Bayulkem K, Soyer P, Deva E. Toxic polyneuropathy due to n-hexan.III.National Neurology Congress, the Book of Presentation Summaries 1990:113.

Erisir K, Bayulkem K, Kumbasar B.Neurological Complications of Sarcoidosis due to a case with a facial diplegia. IV.National Neurology Congress, the Book of Presentation Summaries 1991:74-75,

Bayulkem K, Ersir K, Tanyeri S, Tonyali B. Progressive supranuclear palsy: A case report. IV.National Neurology Congress, the Book of Presentation Summaries 1991:80-81.

Bayulkem K, Kotil K, Erisir K. Intrarcanial multiple tuberculoma: A case report. IV.National Neurology Congress, the Book of Presentation Summaries 1991:137.

Erisir K, Tonyali B, Bayulkem K.Two hemiballismus cases due to lacunars infarct.V.Natioanal Neurology Congress, the Book of Presentation Summaries 1992:86.

Mert M, Karanfil H, Bayulkem K. A Gross meningioma case showing peculiarity, Turkish Hospital Medical Journal (THMJ) 1994; 3-4:25.

Karabas G, Erkal B, Yilmaz A, Bayulkem K. Parkinsonism due to methoclopramide and mixt type Polyneuropathy in a patient with acute renal failure. XXVIII. National Neurology Congress, Special Issue 2002; 19-23.

Yildiz Y, Aslantugrul E, Tokay T, Selekler M, Bayulkem K. Neurofibromatosis case with epileptic Attacks: A case report. XXXIX. National Neurology Congress. The Book of Presentation Summaries 2003; 394-395.

BOOK AND CHAPTER WRITINGS:

Bayulkem K. Parkinson’s disease and Movement Disorders. I. Parkinson’s disease and Movement Disorders Symposium’s Book.Ed. Kemal Bayulkem, 10/29/1994, Aydin- Turkey

Bayulkem K. Antimigraine drugs, Ed.Ismet Dokmeci.Pharmachology, Main concepts in drug applications, Saray Medical Publishing, Bornova-Izmir, 1, 44:499-508, 1996.

Bayulkem K, Erisir K, Tuncel A, Bayulkem B. A study on the effect and tolerance of lisuride on Parkinson’s disease. Advances in Neurology, Volume 69, edited by L.Battistin, G.Scarlato, T.Caraceni and S.Ruggieri. Lippncott-Raven Publishers, Philadelphia, 65:519-530, 1996.

Bayulkem K. Case presentations in movement disorders. In: X. Degenerative disease of nervous system. Ed .Hulya Apaydin, The Lesson Book of Clinical Neurology.Istanbul,643-657,2009. Cerrahpasa Medical Faculty of Istanbul University’s Publishes, Faculty publication. No:260,University publication No:4748

Bayulkem K. Vertigo and balance in:I. Neurologic diagnosis and location. Ed .Hulya Apaydin, The Lesson Book of Clinical Neurology Istanbul,81-104,2009. Cerrahpasa Medical Faculty of Istanbul University’s Publishes, Faculty publication No:260,University publication No:4748 12

Contact

E-Mail :
kemal.bayuklem@gmail.com

a.kemal.bayulkem@medikent.com.tr

Place of Birth : Istanbul